Skip to main content
. Author manuscript; available in PMC: 2017 Feb 5.
Published in final edited form as: J Surg Oncol. 2016 Dec 14;115(2):116–121. doi: 10.1002/jso.24418

TABLE I.

Baseline Characteristics of Premenopausal Patients Diagnosed With Stages I–III ER+ and/or PR+ Breast Cancer Between 2004 and 2006, Advised to Take Adjuvant Tamoxifen (n =278)

Demographics for patients in the pre-oncofertility program cohort from 2004 to 2006
Characteristic No. of patients % of total cohort
Age at diagnosis (years)
 <37 70 25.2
 >37 208 74.8
Median age 41
Race/ethnicity
 White 201 72.3
 Black 30 10.8
 Hispanic 24 8.6
 Asian 11 4.0
 Other 4 1.4
 Missing 8 2.9
Marital status
 Unmarried 86 30.9
 Married, partnered, domestic partner 191 68.7
 Missing 1 0.4
Smoking status
 Current smoker 22 7.9
 Never smoker 209 75.2
 Former smoker 44 15.8
 Missing 3 1.1
Alcohol use
 None or <1 drink per week 130 46.8
 1–4 drinks per week 101 36.3
 5–9 drinks per week 34 12.2
 10–19 drinks per week 7 2.5
 >19 drinks per week 2 0.7
 Missing 4 1.4
Parity
 Nulliparous 94 33.8
 Parity >1 175 62.9
 Missing 9 3.2
Insurance status
 Private insurance 232 83.5
 Public insurance/uninsured 46 16.5
Fertility concerns
 Desires future fertility at diagnosis 37 13.3
 Does not express fertility concerns at diagnosis 241 86.7
Surgery
 Mastectomy 122 43.9
 Lumpectomy 155 55.8
 Axillary dissection only 1 0.3
Chemotherapy (among patients with stage >1)
 No 52 21.6.
 Yes 188 78.0
 Missing 1 0.4
Radiation
 Patient declined 12 4.3
 Yes 194 69.8
 XRT not indicated 70 25.2
 Missing 2 0.7
Stage
 0 37 13.3
 I 96 34.5
 II 102 36.7
 III 43 15.5